Sculptor Capital LP Cassava Sciences Inc Put Options Transaction History

Sculptor Capital LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $635,792 - $1.51 Million	50,300 New	50,300 $1.13 Million
Q4 2022 Feb 14, 2023	SELL	$27.82 - $44.16 $139,100 - $220,799	-5,000 Reduced 6.54%	71,500 $2.11 Million
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $325,458 - $727,083	18,900 Added 32.81%	76,500 $2.15 Million
Q1 2022 May 13, 2022	SELL	$32.6 - $53.05 $4.85 Million - $7.9 Million	-148,900 Reduced 72.11%	57,600 $2.14 Million
Q4 2021 Feb 11, 2022	SELL	$36.77 - $90.91 $1.09 Million - $2.7 Million	-29,700 Reduced 12.57%	206,500 $9.02 Million
Q3 2021 Nov 12, 2021	BUY	$41.79 - $135.3 $8.6 Million - $27.9 Million	205,900 Added 679.54%	236,200 $14.7 Million
Q3 2020 Nov 12, 2020	BUY	$2.86 - $11.51 $86,658 - $348,753	30,300 New	30,300 $348,000

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $94.2M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.